Latest News about financial results
Recent news which mentions financial results
Aurora Reports 20% YoY Uptick In Global Medical Marijuana, Expects Benefits From International Cannabis Regulatory Reforms
June 20, 2024
From Benzinga
Marijuana Fintech Co. POSaBIT Reports 67% YoY Drop In Q1 Revenue, Renews Focus On Sustainable Profitability And Growth
June 14, 2024
From Benzinga
From Benzinga
Grown Rogue Reports Record Q1 Revenue, CEO Calls These Two States 'Primary Growth Drivers'
May 30, 2024
From Benzinga
Entourage Health Cannabis Reports 9% YoY Increase In Q1 Revenue, Positive EBITDA And 'Substantial Growth'
May 28, 2024
From Benzinga
From Benzinga
California Cannabis Co. Gold Flora Reports 150% YoY Increase In Q1 Gross Profit, Trims Loss Sequentially
May 15, 2024
Tickers
NEWS
From Benzinga
From Benzinga
Cannabis Company iAnthus Trims Net Loss In Q1, Reports YoY Increase In Revenue, Gross Profit
May 14, 2024
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
CBD of Denver Reports YoY Increase In 2023 Gross Profit, Reduces Loss As It Continues To Expand Internationally
May 02, 2024
From Benzinga
Revenue Growth And Cannabis Market Expansion: RIV Capital's Fiscal Highlights For 2023
April 30, 2024
From Benzinga
Numinus Wellness Q2 2024 Revenue Declines Amid Clinic Reshuffling And Expected Industry Trends
April 15, 2024
From Benzinga
International Expansion Drives Growth For This Canadian Cannabis Producer As It Reports Record Q1 Revenue
April 15, 2024
From Benzinga
From Benzinga
Female-Led California Weed Co. Gold Flora's Net Loss Grows In Q4, Reports YoY Increase In Revenue & Gross Profit
April 05, 2024
From Benzinga
Lifeist Reports Highest Quarterly Gross Profit In History, Continues To Diversify Its Wellness Business
April 02, 2024
From Benzinga
Cannabinoid-Based Products Maker Sees Triple-Digit Growth In 2023 Gross Profit, Revenue Surges 314% YoY
April 02, 2024
From Benzinga
Atai Life Sciences Q4 And Full-Year 2023 Results: Steep Cash Drain Yet 2026 Target Remains, Update On Psychedelic Pipeline
March 29, 2024
From Benzinga
Hemp-Focused Wellness Co. Moves Closer To Profitability, Reports Flat 2023 Revenue, Increase In Gross Profit
March 28, 2024
From Benzinga
IM Cannabis' Q4 Revenue: Gross Profit Drops Due To Negative Impact Of Israel-Hamas War, Sees Germany As Growth Opportunity
March 28, 2024
From Benzinga
This Cannabinoids-Focused Pharma Co. Sees 50% YoY Surge In Revenue In 2023, Trims Losses
March 27, 2024
From Benzinga
Enveric Biosciences Optimistic On Q4 And Full-Year Results: 'Psychedelic-Inspired' Meds For Future Growth
March 27, 2024
Tickers
ENVB
From Benzinga
Body and Mind's Q2 Revenue Flat YoY, Narrows Loss By 94%
March 26, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.